BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Provectus Pharmaceuticals Inc. CEO Craig Dees, PhD Issues Executive Overview Letter

  January 9, 2008

   · 

  1 min read
• Drug Development

  Somaxon Pharmaceuticals, Inc. Announces Completion of 26-Week Transgenic Mouse Carcinogenicity Study of SILENOR(TM)

  January 9, 2008

   · 

  1 min read
• Business

  NanoString Technologies Inc. Signs Second Early–Access Agreement for the nCounter™ Analysis System

  January 9, 2008

   · 

  1 min read
• Drug Development

  VIVUS, Inc. Initiates Extension Study with Qnexa for Diabetes

  January 9, 2008

   · 

  1 min read
• Biotech Beach

  Xencor Receives Patent for its Proprietary Antibody Fc Optimization Technology

  January 9, 2008

   · 

  1 min read
• Business

  Helicos BioSciences Corporation Announces MicroRNA Collaboration with miRNA Expert

  January 9, 2008

   · 

  1 min read
• Biotech Bay

  Velocity11 Will Present “Automating Applications in a Protected Environment’’ at LabAutomation2008

  January 9, 2008

   · 

  1 min read
• Dyadic International, Inc. Announces Receipt of Purported Declaration of Default from Mark A. Emalfarb Trust and Other Events

  January 9, 2008

   · 

  1 min read
• Drug Development

  Safety Monitoring Committee Recommends That Emergent BioSolutions Continue Its Hepatitis B Immunotherapy Phase II Trial

  January 9, 2008

   · 

  1 min read
• Business

  Q-Med AB and Palomar Medical Technologies Enter into International Distribution Agreement, Q-Med AB to Distribute Palomar Products Outside North America

  January 9, 2008

   · 

  1 min read